Whether you realize it or not, for over a year now, picking growth stocks that perform well has been much easier than usual. After climbing 43% in 2023, the Nasdaq Composite index is still up by a healthy 39% over the past 12 months.

Despite such a big run-up for the major market index most associated with growth stocks, investment bank analysts who follow the biopharmaceutical industry expect more gains ahead from a pair of exceptional businesses.

Image source: Getty Images.

Continue reading

Source Fool.com